Ken Griffin Co Diagnostics, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 22,900 shares of CODX stock, worth $36,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,900
Previous 73,800
68.97%
Holding current value
$36,411
Previous $98,000
74.49%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding CODX
# of Institutions
46Shares Held
4.23MCall Options Held
22.9KPut Options Held
30.4K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.83 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny600KShares$954,6360.0% of portfolio
-
Black Rock Inc. New York, NY500KShares$795,0790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA294KShares$468,1300.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$433,9110.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $53.7M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...